The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Bacterial flagellin—a potent immunomodulatory agent
Open accessAbstract
Flagellin is a subunit protein of the flagellum, a whip-like appendage that enables bacterial motility. Traditionally, flagellin was viewed as a virulence factor that contributes to the adhesion and invasion of host cells, but now it has emerged as a potent immune activator, shaping both the innate and adaptive arms of immunity during microbial infections. In this review, we summarize our understanding of bacterial flagellin and host immune system interactions and the role flagellin as an adjuvant, anti-tumor and radioprotective agent, and we address important areas of future research interests. Flagellin, a protein in the whip-like flagella powering bacterial motion, can activate different parts of the immune system in several ways. John Hwa Lee and a colleague at Chonbuk National University in South Korea, with co-workers at the University of Toledo in USA, reviewed current understanding of the interactions between flagellin and host immune systems. A range of biochemical effects allows flagellin to activate both non-specific “innate” immunity and the “adaptive” immune system that responds to and remembers specific infections. Flagellin can act as a molecule that enhances the immune response, and as an anti-tumor agent, and can offer protection against the damaging effects of exposure to radiation. These activities suggest that the medical potential of flagellin should be explored further, especially in cancer treatment and the development of new vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658
MAP kinase signalling cascade in Arabidopsis innate immunity
Asai, T., Tena, G., Plotnikova, J., Willmann, M. R., Chiu, W.-L., Gomez-Gomez, L., Boller, T., Ausubel, F. M., & Sheen, J. (2002) · Nature · doi:10.1038/415977a · Cited by 2,726
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
Hueck, C. J. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.2.379-433.1998 · Cited by 2,394
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. J. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,506
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J., & Madara, J. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1882 · Cited by 1,346
Jung, H. C., Eckmann, L., Yang, S. K., Panja, A., Fierer, J., Morzycka-Wroblewska, E., & Kagnoff, M. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117676 · Cited by 1,197
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf
Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., & Aderem, A. (2006) · Nature Immunology · doi:10.1038/ni1344 · Cited by 1,127
Toll-like receptors stimulate human neutrophil function
Hayashi, F., Means, T. K., & Luster, A. D. (2003) · Blood · doi:10.1182/blood-2003-04-1078 · Cited by 939
Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity
Kofoed, E. M., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10394 · Cited by 891
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Bacterial flagellin is a dominant antigen in Crohn disease
Lodes, M. J., Cong, Y., Elson, C. O., Mohamath, R., Landers, C. J., Targan, S. R., Fort, M., & Hershberg, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420295 · Cited by 802
Control of B-cell responses by Toll-like receptors
Pasare, C., & Medzhitov, R. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752
Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy
Yonekura, K., Maki-Yonekura, S., & Namba, K. (2003) · Nature · doi:10.1038/nature01830 · Cited by 746
Uematsu, S., Fujimoto, K., Jang, M. H., Yang, B.-G., Jung, Y.-J., Nishiyama, M., Sato, S., Tsujimura, T., Yamamoto, M., Yokota, Y., et al. (2008) · Nature Immunology · doi:10.1038/ni.1622 · Cited by 745
Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 725
Worbs, T., Bode, U., Yan, S., Hoffmann, M. W., Hintzen, G., Bernhardt, G., Förster, R., & Pabst, O. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052016 · Cited by 718
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Burdelya, L. G., Krivokrysenko, V. I., Tallant, T. C., Strom, E., Gleiberman, A. S., Gupta, D., Kurnasov, O. V., Fort, F. L., Osterman, A. L., DiDonato, J. A., et al. (2008) · Science · doi:10.1126/science.1154986 · Cited by 705
Evasion of Toll-like receptor 5 by flagellated bacteria
Andersen-Nissen, E., Smith, K. D., Strobe, K. L., Barrett, S. L. R., Cookson, B. T., Logan, S. M., & Aderem, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502040102 · Cited by 657
Hawn, T. R., Verbon, A., Lettinga, K. D., Zhao, L. P., Li, S. S., Laws, R. J., Skerrett, S. J., Beutler, B., Schroeder, L., Nachman, A., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031220 · Cited by 609
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9537 · Cited by 588
Lightfield, K. L., Persson, J., Brubaker, S. W., Witte, C. E., von Moltke, J., Dunipace, E. A., Henry, T., Sun, Y.-H., Cado, D., Dietrich, W. F., et al. (2008) · Nature Immunology · doi:10.1038/ni.1646 · Cited by 493
TLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer
Kelly, M. G., Alvero, A. B., Chen, R., Silasi, D.-A., Abrahams, V. M., Chan, S., Visintin, I., Rutherford, T., & Mor, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3948 · Cited by 488
Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa
Ramos, H. C., Rumbo, M., & Sirard, J.-C. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.09.002 · Cited by 485
Radioprotectors and mitigators of radiation-induced normal tissue injury
Citrin, D., Cotrim, A. P., Hyodo, F., Baum, B. J., Krishna, M. C., & Mitchell, J. B. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-s104 · Cited by 482
TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells
Salaun, B., Coste, I., Rissoan, M.-C., Lebecque, S. J., & Renno, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4894 · Cited by 479
The role of interleukin-6 in mucosal IgA antibody responses in vivo
Ramsay, A. J., Husband, A. J., Ramshaw, L. A., Bao, S., Matthaei, K. I., Koehler, G., & Kopf, M. (1994) · Science · doi:10.1126/science.8160012 · Cited by 454
Uematsu, S., Jang, M. H., Chevrier, N., Guo, Z., Kumagai, Y., Yamamoto, M., Kato, H., Sougawa, N., Matsui, H., Kuwata, H., et al. (2006) · Nature Immunology · doi:10.1038/ni1362 · Cited by 450
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells
Tezuka, H., Abe, Y., Iwata, M., Takeuchi, H., Ishikawa, H., Matsushita, M., Shiohara, T., Akira, S., & Ohteki, T. (2007) · Nature · doi:10.1038/nature06033 · Cited by 405
Flagellin as an Adjuvant: Cellular Mechanisms and Potential
Mizel, S. B., & Bates, J. T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002156 · Cited by 399
Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021109 · Cited by 381
Crellin, N. K., Garcia, R. V., Hadisfar, O., Allan, S. E., Steiner, T. S., & Levings, M. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8051 · Cited by 375
Nossal, G. J. V., Austin, C. M., Pye, J., & Mitchell, J. (1966) · International Archives of Allergy and Immunology · doi:10.1159/000229718 · Cited by 371
Sierro, F., Dubois, B., Coste, A., Kaiserlian, D., Kraehenbuhl, J.-P., & Sirard, J.-C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241308598 · Cited by 368
Sharpe, A. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00784.x · Cited by 357
Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells
手塚, 裕., 安部, 由., & 樗木, 俊. (2008) · 生体の科学 · Cited by 322
Flagellin Promotes Myeloid Differentiation Factor 88-Dependent Development of Th2-Type Response
Didierlaurent, A., Ferrero, I., Otten, L. A., Dubois, B., Reinhardt, M., Carlsen, H., Blomhoff, R., Akira, S., Kraehenbuhl, J.-P., & Sirard, J.-C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6922 · Cited by 310
Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J., Dziarski, R., Akira, S., Schoenberger, S. P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4102 · Cited by 302
Huleatt, J. W., Jacobs, A. R., Tang, J., Desai, P., Kopp, E. B., Huang, Y., Song, L., Nakaar, V., & Powell, T. J. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.013 · Cited by 299
Honko, A. N., Sriranganathan, N., Lees, C. J., & Mizel, S. B. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1113-1120.2006 · Cited by 278
Eaves-Pyles, T., Murthy, K., Liaudet, L., Virág, L., Ross, G., Soriano, F. G., Szabó, C., & Salzman, A. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1248 · Cited by 270
Bacterial Flagellin Is an Effective Adjuvant for CD4+ T Cells In Vivo
McSorley, S. J., Ehst, B. D., Yu, Y., & Gewirtz, A. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3914 · Cited by 256
Szczepanski, M. J., Czystowska, M., Szajnik, M., Harasymczuk, M., Boyiadzis, M., Kruk-Zagajewska, A., Szyfter, W., Zeromski, J., & Whiteside, T. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3838 · Cited by 253
Steiner, T. S., Nataro, J. P., Poteet-Smith, C. E., Smith, J. A., & Guerrant, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8892 · Cited by 248
Characterization of CD4+ T Cell Responses During Natural Infection with Salmonella typhimurium
McSorley, S. J., Cookson, B. T., & Jenkins, M. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.986 · Cited by 238
Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses
Rojas, M., Woods, C. R., Mora, A. L., Xu, J., & Brigham, K. L. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00334.2004 · Cited by 236
Flagellin Is the Major Proinflammatory Determinant of Enteropathogenic Salmonella
Zeng, H., Carlson, A. Q., Guo, Y., Yu, Y., Collier-Hyams, L. S., Madara, J. L., Gewirtz, A. T., & Neish, A. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3668 · Cited by 235
Lee, S. E., Kim, S. Y., Jeong, B. C., Kim, Y. R., Bae, S. J., Ahn, O. S., Lee, J.-J., Song, H.-C., Kim, J. M., Choy, H. E., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.1.694-702.2006 · Cited by 226
Self-citationProminent Role for Plasmacytoid Dendritic Cells in Mucosal T Cell-Independent IgA Induction
Tezuka, H., Abe, Y., Asano, J., Sato, T., Liu, J., Iwata, M., & Ohteki, T. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.002 · Cited by 224
Tomato receptor FLAGELLIN-SENSING 3 binds flgII-28 and activates the plant immune system
Hind, S. R., Strickler, S. R., Boyle, P. C., Dunham, D. M., Bao, Z., O'Doherty, I. M., Baccile, J. A., Hoki, J. S., Viox, E. G., Clarke, C. R., et al. (2016) · Nature Plants · doi:10.1038/nplants.2016.128 · Cited by 217
Cai, Z., Sanchez, A., Shi, Z., Zhang, T., Liu, M., & Zhang, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1993 · Cited by 214
Schmaußer, B., Andrulis, M., Endrich, S., Müller-Hermelink, H.-K., & Eck, M. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.02.009 · Cited by 208
Mizel, S. B., Honko, A. N., Moors, M. A., Smith, P. S., & West, A. P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6217 · Cited by 203
Flagellin Treatment Protects against Chemicals, Bacteria, Viruses, and Radiation
Vijay-Kumar, M., Aitken, J. D., Sanders, C. J., Frias, A., Sloane, V. M., Xu, J., Neish, A. S., Rojas, M., & Gewirtz, A. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8280 · Cited by 201
Trdá, L., Fernandez, O., Boutrot, F., Héloir, M., Kelloniemi, J., Daire, X., Adrian, M., Clément, C., Zipfel, C., Dorey, S., et al. (2014) · New Phytologist · doi:10.1111/nph.12592 · Cited by 195
Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer
Sfondrini, L., Rossini, A., Besusso, D., Merlo, A., Tagliabue, E., Mènard, S., & Balsari, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6624 · Cited by 194
Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses
Cuadros, C., Lopez-Hernandez, F. J., Dominguez, A. L., McClelland, M., & Lustgarten, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.5.2810-2816.2004 · Cited by 188
A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity
McDonald, W. F., Huleatt, J. W., Foellmer, H. G., Hewitt, D., Tang, J., Desai, P., Price, A., Jacobs, A., Takahashi, V. N., Huang, Y., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/517613 · Cited by 185
Rhee, S. H., Im, E., & Pothoulakis, C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.022 · Cited by 183
Effects of Flagellin on Innate and Adaptive Immunity
Honko, A. N., & Mizel, S. B. (2005) · Immunologic Research · doi:10.1385/ir:33:1:083 · Cited by 170
McDermott, P. F., Ciacci-Woolwine, F., Snipes, J. A., & Mizel, S. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5525-5529.2000 · Cited by 161
Taylor, D. N., Treanor, J. J., Strout, C., Johnson, C., Fitzgerald, T., Kavita, U., Ozer, K., Tussey, L., & Shaw, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.001 · Cited by 160
SalmonellaFlagellin Induces Tumor Necrosis Factor Alpha in a Human Promonocytic Cell Line
Ciacci-Woolwine, F., Blomfield, I. C., Richardson, S. H., & Mizel, S. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1127-1134.1998 · Cited by 154
A conserved TLR5 binding and activation hot spot on flagellin
Song, W. S., Jeon, Y. J., Namgung, B., Hong, M., & Yoon, S. (2017) · Scientific Reports · doi:10.1038/srep40878 · Cited by 153
Berin, M. C., Darfeuille–Michaud, A., Egan, L. J., Miyamoto, Y., & Kagnoff, M. F. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00218.x · Cited by 150
Treanor, J. J., Taylor, D. N., Tussey, L., Hay, C. M., Nolan, C., Fitzgerald, T. F., Liu, G., Kavita, U., Song, L., Dark, I., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.009 · Cited by 147
TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin
Vijay‐Kumar, M., Carvalho, F. A., Aitken, J. D., Fifadara, N. H., & Gewirtz, A. T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040421 · Cited by 145
Eaves-Pyles, T. D., Wong, H. R., Odoms, K., & Pyles, R. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7009 · Cited by 141
Wang, B., Quan, F., Kang, S., Bozja, J., Skountzou, I., & Compans, R. W. (2008) · Journal of Virology · doi:10.1128/jvi.01076-08 · Cited by 138
Mizel, S. B., Graff, A. H., Sriranganathan, N., Ervin, S. E., Lees, C. J., Lively, M. O., Hantgan, R. R., Thomas, M. J., Wood, J. F., & Bell, B. A. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00333-08 · Cited by 137
Bargieri, D. Y., Rosa, D. S., Braga, C. J. M., Carvalho, B. O., Costa, F. T. M., Espíndola, N. M., Vaz, A. J., Soares, I. S., Ferreira, L. C. D. S., & Rodrigues, M. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.070 · Cited by 133
Mucosal Administration of Flagellin Induces Innate Immunity in the Mouse Lung
Honko, A. N., & Mizel, S. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6676-6679.2004 · Cited by 131
Murthy, K. G. K., Deb, A., Goonesekera, S. D., Szabó, C., & Salzman, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307759200 · Cited by 128
Huang, J., Yin, Y., Pan, Z., Zhang, G., Zhu, A., Liu, X., & Jiao, X. (2010) · BioMed Research International · doi:10.1155/2010/589476 · Cited by 127
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist
Burdelya, L. G., Brackett, C. M., Kojouharov, B., Gitlin, I. I., Leonova, K. I., Gleiberman, A. S., Aygun‐Sunar, S., Veith, J. M., Johnson, C., Haderski, G. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222805110 · Cited by 124
Wyant, T. L., Tanner, M. K., & Sztein, M. B. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3619-3624.1999 · Cited by 124
Skountzou, I., Martin, M. D. P., Wang, B., Ye, L., Koutsonanos, D., Weldon, W., Jacob, J., & Compans, R. W. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.058 · Cited by 121
Humoral Immune Response to Flagellin Requires T Cells and Activation of Innate Immunity
Sanders, C. J., Yu, Y., Moore, D. A., Williams, I. R., & Gewirtz, A. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2810 · Cited by 120
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview
Stockfleth, E., Trefzer, U., Garcia-Bartels, C., Wegner, T., Schmook, T., & Sterry, W. (2003) · British Journal of Dermatology · doi:10.1046/j.0366-077x.2003.05626.x · Cited by 119
Song, L., Nakaar, V., Kavita, U., Price, A., Huleatt, J., Tang, J. T., Jacobs, A., Liu, G., Huang, Y., Desai, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002257 · Cited by 115
Tedla, N. T., Wang, H. W., McNeil, H. P., Girolamo, N. D., Hampartzoumian, T., Wakefield, D., & Lloyd, A. R. (1998) · PubMed · Cited by 109
Divergence of Quaternary Structures Among Bacterial Flagellar Filaments
Galkin, V. E., Yu, X., Bielnicki, J., Heuser, J., Ewing, C. P., Guerry, P., & Egelman, E. H. (2008) · Science · doi:10.1126/science.1155307 · Cited by 108
Vassilieva, E. V., Wang, B., Vzorov, A. N., et al. (2011) · mBio · doi:10.1128/mbio.00328-10 · Cited by 106
Brackett, C. M., Kojouharov, B., Veith, J. M., Greene, K. F., Burdelya, L. G., Gollnick, S. O., Abrams, S. I., & Gudkov, A. V. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521359113 · Cited by 103
Karam, M. R. A., Oloomi, M., Mahdavi, M., Habibi, M., & Bouzari, S. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.059 · Cited by 100
Evaluation of a Truncated Recombinant Flagellin Subunit Vaccine against Campylobacter jejuni
Lee, L. H., Burg, E. F., Baqar, S., Bourgeois, A. L., Burr, D. H., Ewing, C. P., Trevor J. TRUST, & Guerry, P. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5799-5805.1999 · Cited by 97
A universal epitope-based influenza vaccine and its efficacy against H5N1
Adar, Y., Singer, Y., Levi, R., Tzehoval, E., Perk, S., Banet-Noach, C., Nagar, S., Arnon, R., & Ben-Yedidia, T. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.011 · Cited by 97
Tedla, N. T., Wang, H., McNeil, H. P., Girolamo, N. D., Hampartzoumian, T., Wakefield, D., & Lloyd, A. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5663 · Cited by 95
Song, L., Zhang, Y., Yun, N. E., Poussard, A. L., Smith, J. N., Smith, J. K., Borisevich, V., Linde, J., Zacks, M. A., Li, H., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.060 · Cited by 94
Nguyen, C. T., Kim, S. Y., Kim, M. S., Lee, S. E., & Rhee, J. H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.095 · Cited by 93
Nguyen, C. T., Hong, S. H., Sin, J., Vu, H. V. D., Jeong, K., Cho, K. O., Uematsu, S., Akira, S., Lee, S. E., & Rhee, J. H. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.054 · Cited by 91
Tsujimoto, H., Uchida, T., Efron, P. A., Scumpia, P. O., Verma, A., Matsumoto, T., Tschoeke, S. K., Ungaro, R. F., Ono, S., Seki, S., et al. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0105051 · Cited by 91
Levi, R. (1996) · Vaccine · doi:10.1016/0264-410x(95)00088-i · Cited by 90
Weimer, E. T., Lu, H., Kock, N. D., Wozniak, D. J., & Mizel, S. B. (2009) · Infection and Immunity · doi:10.1128/iai.00054-09 · Cited by 87
Toll-like receptor signaling in anti-cancer immunity.
Okamoto, M., & Sato, M. (2003) · PubMed · Cited by 87
Toll-like Receptor Signaling Stimulates Cell Cycle Entry and Progression in Fibroblasts
Hasan, U. A., Trinchieri, G., & Vlach, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500877200 · Cited by 86
Over-activation of TLR5 signaling by high-dose flagellin induces liver injury in mice
Xiao, Y., Liu, F., Yang, J., Zhong, M., Zhang, E., Li, Y., Zhou, D., Cao, Y., Li, W., Yu, J., et al. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.110 · Cited by 82
McCarron, M. J., & Reen, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.55 · Cited by 80
Intestinal Epithelial Toll-Like Receptors: To Protect. And Serve?
Gewirtz, A. T. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392422 · Cited by 78
Kauppila, J. H., Mattila, A. E., Karttunen, T. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.589 · Cited by 76
Liu, G., Tarbet, E. B., Song, L., Reiserová, L., Weaver, B., Chen, Y., Li, H., Hou, F., Liu, X., Parent, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020928 · Cited by 71
Flagellin Induces Antibody Responses through a TLR5- and Inflammasome-Independent Pathway
López-Yglesias, A. H., Zhao, X., Quarles, E. K., Lai, M. A., VandenBos, T., Strong, R. K., & Smith, K. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301893 · Cited by 70
Effects of interleukin 4 on CD25+CD4+ regulatory T cell function
Maerten, P., Shen, C., Bullens, D. M. A., Assche, G. V., Gool, S. V., Geboes, K. J., Rutgeerts, P. J., & Ceuppens, J. L. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.04.001 · Cited by 68
Toll-Like Receptor 11 (TLR11) Interacts with Flagellin and Profilin through Disparate Mechanisms
Hatai, H., Lepelley, A., Zeng, W., Hayden, M. S., & Ghosh, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148987 · Cited by 68
Salazar-Gonzalez, R.-M., Srinivasan, A., Griffin, A., Muralimohan, G., Ertelt, J. M., Ravindran, R., Vella, A. T., & McSorley, S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6169 · Cited by 67
Benkő, S., Magyarics, Z., Szabó, A., & Rajnavölgyi, É. (2008) · Biological Chemistry · doi:10.1515/bc.2008.054 · Cited by 66
Mucosal adjuvant activity of flagellin in aged mice
Bates, J. T., Honko, A. N., Graff, A. H., Kock, N. D., & Mizel, S. B. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.01.009 · Cited by 64
Leigh, N. D., Bian, G., Ding, X., Liu, H., Aygun‐Sunar, S., Burdelya, L. G., Gudkov, A. V., & Cao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085587 · Cited by 63
Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine
Ben-Yedidia, T., & Arnon, R. (1998) · Immunology Letters · doi:10.1016/s0165-2478(98)00073-x · Cited by 60
Ben-Yedidia, T., Marcus, H., Reisner, Y., & Arnon, R. (1999) · International Immunology · doi:10.1093/intimm/11.7.1043 · Cited by 60
Delaney, K. N., Phipps, J. P., Johnson, J. B., & Mizel, S. B. (2010) · Viral Immunology · doi:10.1089/vim.2009.0107 · Cited by 59
Braga, C. J. M., Massis, L. M., Sbrogio-Almeida, M. E., de Alencar, B. C., Bargieri, D. Y., Boscardin, S. B., Rodrigues, M. M., & Ferreira, L. C. D. S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.003 · Cited by 57
Both Radioresistant and Hemopoietic Cells Promote Innate and Adaptive Immune Responses to Flagellin
Sanders, C. J., Moore, D. A., Williams, I. R., & Gewirtz, A. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7184 · Cited by 55
Anti‐metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10
de Melo, F. M., Braga, C. J., Pereira, F. V., Maricato, J. T., Origassa, C. S. T., de Souza, M. F. C., de Melo, A. C. L., Silva, P., Tomaz, S. L., Gimenes, K. P., et al. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.74 · Cited by 55
Flagellin as Carrier and Adjuvant in Cocaine Vaccine Development
Lockner, J. W., Eubanks, L. M., Choi, J. L., Lively, J. M., Schlosburg, J. E., Collins, K. C., Globisch, D., Gunn, R. J., Wilson, I. A., & Janda, K. D. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500520r · Cited by 55
Vicente-Suarez, I., Brayer, J. B., Villagra, A., Cheng, F., & Sotomayor, E. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.007 · Cited by 55
Yin, G., Qin, M., Liu, X., Suo, J., Tang, X., Tao, G., Han, Q., Suo, X., & Wu, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.088 · Cited by 49
Liu, G., Song, L., Reiserová, L., Trivedi, U., Li, H., Liu, X., Noah, D. L., Hou, F., Weaver, B., & Tussey, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.013 · Cited by 47
Ильдарович, Т. А., Gitlin, I. I., Shcheblyakov, D. V., Artemicheva, N. M., Burdelya, L. G., Шмаров, М. М., Naroditsky, B. S., Gudkov, A. V., Al, G., & Logunov, D. Y. (2013) · Infection and Immunity · doi:10.1128/iai.00525-13 · Cited by 46
Lacavé-Lapalun, J.-V., Benderitter, M., & Linard, C. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204040 · Cited by 44
Yu, X., Guo, C., Yi, H., Qian, J., Fisher, P. B., Subjeck, J. R., & Wang, X. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1740 · Cited by 43
Kojouharov, B., Brackett, C. M., Veith, J. M., Johnson, C. P., Gitlin, I. I., Toshkov, I. A., Gleiberman, A. S., Gudkov, A. V., & Burdelya, L. G. (2014) · Oncotarget · doi:10.18632/oncotarget.1773 · Cited by 42
Ben-Yedidia, T., Tarrab-Hazdai, R., Schechtman, D., & Arnon, R. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4360-4366.1999 · Cited by 42
Efficacy of anti-influenza peptide vaccine in aged mice
Ben-Yedidia, T., Abel, L., Arnon, R., & Globerson, A. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00045-1 · Cited by 41
Qi, Y., Kang, H., Zheng, X., Wang, H., Gao, Y., Yang, S., & Xia, X. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00169 · Cited by 34
Inhibition of Airway Allergic Disease by Co-Administration of Flagellin with Allergen
Lee, S. E., Koh, Y., Kim, M.-K., Kim, Y. R., Kim, S. Y., Nam, J. H., Choi, Y. D., Bae, S. J., Ko, Y. J., Ryu, H.-J., et al. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9138-3 · Cited by 33
Shi, M., Yao, Y., Han, F., Li, Y., & Li, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086839 · Cited by 32
Antibody response against Escherichia coli heat-stable enterotoxin expressed as fusions to flagellin
Pereira, C. M., Guth, B. E. C., Sbrogio-Almeida, M. E., & Castilho, B. A. (2001) · Microbiology · doi:10.1099/00221287-147-4-861 · Cited by 32
Phosphorothioate-Modified TLR9 Ligands Protect Cancer Cells against TRAIL-Induced Apoptosis
Chiron, D., Pellat‐Deceunynck, C., Maillasson, M., Bataille, R., & Jégo, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901436 · Cited by 28
Okugawa, S., Yanagimoto, S., Tsukada, K., Kitazawa, T., Koike, K., Kimura, S., Nagase, H., Hirai, K., & Ota, Y. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00731.x · Cited by 27
Hajam, I. A., Dar, P., ChandraSekar, S., Nanda, R. K., Kishore, S., Bhanuprakash, V., & Kondabattula, G. (2013) · Research in Veterinary Science · doi:10.1016/j.rvsc.2013.07.021 · Cited by 27
Self-citationHybrid flagellin as a T cell independent vaccine scaffold
Bennett, K. M., Gorham, R. D., Gusti, V., Trinh, L., Morikis, D., & Lo, D. D. (2015) · BMC Biotechnology · doi:10.1186/s12896-015-0194-0 · Cited by 25
Arimilli, S., Johnson, J. B., Clark, K. M., Graff, A. H., Alexander‐Miller, M. A., Mizel, S. B., & Parks, G. D. (2008) · Journal of Virology · doi:10.1128/jvi.01288-08 · Cited by 24
Flagellin produced in plants is a potent adjuvant for oral immunization
Girard, A., Saron, W. A. A., Bergeron-Sandoval, L.-P., Sarhan, F., & Archambault, D. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.092 · Cited by 22
Camacho, A. G. A., Teixeira, L. H., Bargieri, D. Y., Boscardin, S. B., Soares, I. S., Nussenzweig, R. S., Nussenzweig, V., & Rodrigues, M. M. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000900021 · Cited by 21
Petrof, E. O., Musch, M. W., Ciancio, M. J., Sun, J., Hobert, M. E., Claud, E. C., Gewirtz, A. T., & Chang, E. B. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2007 · Cited by 19
Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant
Rady, H. F., Dai, G., Huang, W., Shellito, J. E., & Ramsay, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148701 · Cited by 19
Hiriart, Y., Rossi, A. H., Biedma, M. E., Errea, A. J., Moreno, G., Cayet, D., Rinaldi, J., Blancá, B., Sirard, J., Goldbaum, F. A., et al. (2017) · Protein Science · doi:10.1002/pro.3151 · Cited by 14
Nyström, S., Bråve, A., Falkeborn, T., Devito, C., Rissiek, B., Johansson, D. X., Schröder, U., Uematsu, S., Akira, S., Hinkula, J., et al. (2013) · Vaccines · doi:10.3390/vaccines1040415 · Cited by 11
Machluf, N., & Arnon, R. (2012) · World Journal of Vaccines · doi:10.4236/wjv.2012.23015 · Cited by 9
Attacking tumor cells with a dual ligand for innate immune receptors
Garaude, J., & Blander, J. M. (2012) · Oncotarget · doi:10.18632/oncotarget.484 · Cited by 6
Izidoro, M. S. (2012) · Journal of Bacteriology & Parasitology · doi:10.4172/2155-9597.1000158 · Cited by 6
Wani, M. Y., Goswami, T. K., Chaudhary, D., Singh, R. P., & Dhama, K. (2014) · International Journal of Pharmacology · doi:10.3923/ijp.2014.389.397 · Cited by 1
Cited by
Silent recognition of flagellins from human gut commensal bacteria by Toll-like receptor 5
(2023) · doi:10.1126/sciimmunol.abq7001 · Cited by 117
Application of built-in adjuvants for epitope-based vaccines
Lei, Y., Zhao, F., Shao, J., Li, Y., Li, S., Chang, H., & Zhang, Y. (2019) · PeerJ · doi:10.7717/peerj.6185 · Cited by 115
Lauté-Caly, D. L., Raftis, E. J., Cowie, P., Hennessy, E., Holt, A., Panzica, D. A., Sparre, C., Minter, B., Stroobach, E., & Mulder, I. E. (2019) · Scientific Reports · doi:10.1038/s41598-018-36926-8 · Cited by 67
Macandog, A. D. G., Catozzi, C., Capone, M., Nabinejad, A., Nanaware, P. P., Liu, S., Vinjamuri, S., Stunnenberg, J. A., Galiè, S., Jodice, M. G., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.006 · Cited by 40
Badten, A. J., & Torres, A. G. (2024) · Vaccines · doi:10.3390/vaccines12030313 · Cited by 8
Metadata
- Authors
- Hajam, I. A., Dar, P. A., Shahnawaz, I., Jaume, J. C., & Lee, J. H.
- Venue
- Experimental & Molecular Medicine
- Published
- 2017-09
- Volume
- 49
- Issue
- 9
- Pages
- e373-e373
- ISSN
- 1226-3613 (ISSN-L)
- 2092-6413
- OpenAlex
- W2753602919
- Cited by
- 387
- References
- 151
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.